Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1996
Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domainA J Bitonti, J A Dumont, F G Salituro, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1995
Regulation of ornithine decarboxylase mRNA levels in human breast cancer cells: pattern of expression and involvement of core enhancer promoter elementP S Wright, J R Cooper, D E Cross-Doersen, et al.
The Journal of Biological Chemistry|July 31, 2001
Expression of p21Waf1/Cip1 and cyclin D1 is increased in butyrate-resistant HeLa cellsA Derjuga, C Richard, M Crosato, et al.
Journal of Medicinal Chemistry|February 15, 2001
Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.
Experimental and Molecular Pathology|February 1, 1997
Quantitation of vascular endothelial growth factor mRNA levels in human breast tumors and metastatic lymph nodesP S Wright, D E Loudy, D E Cross-Doersen, et al.
Cancer Research|March 15, 1994
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductaseA J Bitonti, J A Dumont, T L Bush, et al.
Oncology Research|January 1, 1997
Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731)R D Woessner, D E Loudy, C D Wallace, et al.
Biochemical Pharmacology|May 20, 1998
Clomiphene analogs with activity in vitro and in vivo against human breast cancer cellsR J Baumann, T L Bush, D E Cross-Doersen, et al.
Cell Death and Differentiation|November 17, 2007
RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFRD B Ramnarain, R Paulmurugan, S Park, et al.
Experimental Cell Research|January 10, 1996
A ribonucleotide reductase inhibitor, MDL 101,731, induces apoptosis and elevates TRPM-2 mRNA levels in human prostate tumor xenograftsP S Wright, D Cross-Doersen, J P Th'ng, et al.
Pageof 10